Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-06

Clinical Trial Update: NovaTears® Eye Drops Observational Study

View source ↗

Summary

An observational study of NovaTears Eye Drops for Dry Eye Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NovaTears Eye Drops (perfluorohexyloctane)

Snippet

Sponsor: Novaliq GmbH | Conditions: Dry Eye Disease | Status: COMPLETED